Screener
Eligibility screening
A Phase 1/2 Trial of Bleximenib for Acute Leukemia
27 US sites in AZ, CA, IL, IN +13
Before we begin
Who are you filling this out for?
Your answer affects how the questions are phrased.
Screener
A Phase 1/2 Trial of Bleximenib for Acute Leukemia
27 US sites in AZ, CA, IL, IN +13
Before we begin
Your answer affects how the questions are phrased.